等待開盤 05-20 09:30:00 美东时间
+0.320
+0.88%
Conference call scheduled for Thursday, April 30, 2026, at 8:30 am ET to review new OST-HER2 immune pharmacodynamic biomarker response (seroconversion) data and review regulatory successes validating the OST-HER2
04-30 18:10
Company entered into an asset purchase agreement with Johnson & Johnson (J&J) to acquire all interests in botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa
04-16 19:16
Barclays ETN+ Select MLP ETN ( ($ATMP) ) has issued an announcement. Barclays B...
02-12 03:47
The latest update is out from Barclays ETN+ Select MLP ETN ( ($ATMP) ). Barclay...
2025-10-23 01:47
The latest announcement is out from Barclays ETN+ Select MLP ETN ( ($ATMP) ). B...
2025-07-29 23:47
Pacira BioSciences, Inc. (NASDAQ: PCRX) has announced new long-term follow-up data from its Phase 1 clinical trial of PCRX-201, an investigational gene therapy for osteoarthritis of the knee. The resu...
2025-06-11 20:00
An announcement from Barclays ETN+ Select MLP ETN ( ($ATMP) ) is now available....
2025-04-29 18:29
March 3 (Reuters) - Ocugen Inc OCGN.O: OCUGEN ANNOUNCES POSITIVE OPINION OF EMA’S COMMITTEE FOR ADVANCED THERAPIES FOR ATMP CLASSIFICATION FOR NOVEL MODIFIER GENE THERAPY CANDIDATE OCU410 FOR GEOGRAPH...
2025-03-03 22:53
Barclays ETN+ Select MLP ETN ( ($ATMP) ) has issued an update. Barclays Bank PL...
2025-02-14 22:57
Barclays ETN+ Select MLP ETN ( ($ATMP) ) has shared an announcement. Barclays B...
2025-02-06 06:47